Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MA vs MRNA✓SelectedUSD · MRNAMA vs MRNA performance historyLatest closeAs of-0.15%11/20
Stock and ETF performance explorer

MA vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+57.5%
MRNA return
+153.9%
Excess return
-96.4%
Maximum drawdown
-20.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-0.1%-2.2%+2.0%-0.1%
7D-5.4%-12.7%+7.3%-5.2%
30D+0.5%-20.7%+21.1%+0.7%
3M+9.2%+46.3%-37.1%+8.6%
6M+26.0%+305.2%-279.2%+21.5%
YTD+10.3%+561.2%-551.0%+3.2%
1Y+19.3%+772.1%-752.8%+9.8%
3Y+57.5%+147.0%-89.5%+51.3%
All+57.5%+153.9%-96.4%+51.3%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling